RICHARD SMITH: Open Payments
NPI 1225107824 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,098 in 72 payments from 10 companies in 2025. Trend: 2023 $375 · 2024 $558 · 2025 $1,098
Food & beverage: $1,098
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $269 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 21 | $259 |
| Teva Pharmaceuticals USA, Inc. | 19 | $253 |
| Neurocrine BioSciences, Inc. | 4 | $99 |
| JAZZ PHARMACEUTICALS INC. | 2 | $54 |
| Lundbeck LLC | 2 | $40 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
| E.R. Squibb & Sons, L.L.C. | 2 | $33 |
| Janssen Pharmaceuticals, Inc | 2 | $32 |
| Braeburn Inc. | 1 | $24 |
Products named: VRAYLAR, CAPLYTA, UZEDY, INGREZZA, REXULTI, XYWAV, COBENFY, BRIXADI.
Industry payments across NM — which companies pay providers there.
